Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.02 USD | -0.42% | -0.22% | +63.71% |
May. 13 | Merus Says US FDA Grants Breakthrough Therapy Designation for Petosemtamab | MT |
May. 13 | Merus Carcinoma Treatment Awarded US FDA's Breakthrough Therapy Designation | DJ |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.
- Press Releases